Irreversible inhibition of estrogen receptor α signaling and the emergence of hormonal resistance in MCF7 breast cancer cells induced by DNA damage agents.

Autor: Scherbakov AM; Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation.; Molecular Genetics Laboratory, Institute of Clinical Medicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russian Federation., Sorokin DV; Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation.; Molecular Genetics Laboratory, Institute of Clinical Medicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russian Federation., Razuvaeva VE; Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation., Shchegolev YY; Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation., Andreeva OE; Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation., Salnikova DI; Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation.; Laboratory of Chemical Transformations of Antibiotics, Gause Institute of New Antibiotics, Moscow 119021, Russian Federation., Fetisov TI; Department of Chemical Carcinogenesis, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation., Vlasova OA; Department of Chemical Carcinogenesis, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation., Kirsanov KI; Department of Chemical Carcinogenesis, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation.; Institute of Medicine, Patrice Lumumba Peoples' Friendship University of Russia, Moscow 117198, Russian Federation., Gudkova MV; Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation., Krasil'nikov MA; Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, The Ministry of Health of Russia, Moscow 115522, Russian Federation.; Molecular Genetics Laboratory, Institute of Clinical Medicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russian Federation.

Publikováno v: Biomedical reports [Biomed Rep] 2024 Jan 19; Vol. 20 (3), pp. 42. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).

Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance.

Autor: Andreeva OE; Department of Experimental Tumour Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115522 Moscow, Russia., Sorokin DV; Department of Experimental Tumour Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115522 Moscow, Russia., Mikhaevich EI; Department of Experimental Tumour Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115522 Moscow, Russia., Bure IV; Laboratory of Medical Genetics, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia., Shchegolev YY; Department of Experimental Tumour Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115522 Moscow, Russia., Nemtsova MV; Laboratory of Medical Genetics, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia., Gudkova MV; Department of Experimental Tumour Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115522 Moscow, Russia., Scherbakov AM; Department of Experimental Tumour Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115522 Moscow, Russia., Krasil'nikov MA; Department of Experimental Tumour Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115522 Moscow, Russia.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2021 Nov 03; Vol. 26 (21). Date of Electronic Publication: 2021 Nov 03.

Peculiarities of Molecular Mechanisms Involved in Modification of the Structural and Molecular Organization of the Cell Genome.

Autor: Shabalkin IP; N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation, Moscow, Russia., Grigor'eva EY; N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation, Moscow, Russia. grig-elen11@mail.ru., Gudkova MV; N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation, Moscow, Russia., Stukalov YV; N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2018 May; Vol. 165 (1), pp. 154-156. Date of Electronic Publication: 2018 May 24.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fibonacci Sequence and Supramolecular Structure of DNA.

Autor: Shabalkin IP; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia. margo56@bk.ru., Grigor'eva EY; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Gudkova MV; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Shabalkin PI; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2016 May; Vol. 161 (1), pp. 193-6. Date of Electronic Publication: 2016 Jun 06.